270 related articles for article (PubMed ID: 22211893)
21. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.
Wysocki PJ; Wierusz-Wysocka B
Expert Rev Mol Diagn; 2010 May; 10(4):509-19. PubMed ID: 20465505
[TBL] [Abstract][Full Text] [Related]
22. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome.
McCarty MF
Med Hypotheses; 2005; 64(6):1211-5. PubMed ID: 15823720
[TBL] [Abstract][Full Text] [Related]
23. Metformin and pancreatic cancer: Is there a role?
De Souza A; Khawaja KI; Masud F; Saif MW
Cancer Chemother Pharmacol; 2016 Feb; 77(2):235-42. PubMed ID: 26740120
[TBL] [Abstract][Full Text] [Related]
24. A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control.
Seufert J
Curr Med Res Opin; 2006; 22 Suppl 2():S39-48. PubMed ID: 16914074
[TBL] [Abstract][Full Text] [Related]
25. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
27. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
McFarland MS; Cripps R
Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
[TBL] [Abstract][Full Text] [Related]
28. Diabetes and pancreatic cancer.
Cui Y; Andersen DK
Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
[TBL] [Abstract][Full Text] [Related]
29. Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells.
Tosca L; Ramé C; Chabrolle C; Tesseraud S; Dupont J
Reproduction; 2010 Feb; 139(2):409-18. PubMed ID: 19906888
[TBL] [Abstract][Full Text] [Related]
30. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
31. The management of insulin resistance in polycystic ovary syndrome.
Teede HJ; Hutchison SK; Zoungas S
Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
[TBL] [Abstract][Full Text] [Related]
32. Diabetes and cancer: a 2013 synopsis.
Buysschaert M; Sadikot S
Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin.
Biarnés J; Fernández-Real JM; Fernández-Castañer M; del Mar García M; Soler J; Ricart W
Metabolism; 2005 Feb; 54(2):235-9. PubMed ID: 15690319
[TBL] [Abstract][Full Text] [Related]
34. Metformin: an effective attenuator of risperidone-induced insulin resistance hyperglycemia and dyslipidemia in rats.
Adeneye AA; Agbaje EO; Olagunju JA
Indian J Exp Biol; 2011 May; 49(5):332-8. PubMed ID: 21615056
[TBL] [Abstract][Full Text] [Related]
35. Metformin: do we finally have an anti-aging drug?
Anisimov VN
Cell Cycle; 2013 Nov; 12(22):3483-9. PubMed ID: 24189526
[TBL] [Abstract][Full Text] [Related]
36. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.
Becker S; Dossus L; Kaaks R
Arch Physiol Biochem; 2009 May; 115(2):86-96. PubMed ID: 19485704
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus, hyperglycaemia and cancer.
Simon D; Balkau B
Diabetes Metab; 2010 Jun; 36(3):182-91. PubMed ID: 20554237
[TBL] [Abstract][Full Text] [Related]
38. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
39. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Berstein LM; Egormin PA; Piskunova TS; Popovich IG; Zabezhinski MA; Kovalenko IG; Poroshina TE; Semenchenko AV; Provinciali M; Re F; Franceschi C
Exp Gerontol; 2005; 40(8-9):685-93. PubMed ID: 16125352
[TBL] [Abstract][Full Text] [Related]
40. A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate.
McCarty MF
Med Hypotheses; 1999 Feb; 52(2):89-93. PubMed ID: 10340287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
